CNAB - United Cannabis Corporation

Other OTC - Other OTC Delayed Price. Currency in USD
0.3750
0.0000 (0.00%)
As of 11:15AM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close0.3750
Open0.3675
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.3500 - 0.3750
52 Week Range0.3000 - 0.9200
Volume35,491
Avg. Volume226,525
Market Cap29.131M
Beta (3Y Monthly)-1.97
PE Ratio (TTM)N/A
EPS (TTM)-0.2580
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • GlobeNewswire3 hours ago

    David J. Scott Joins United Cannabis Corp Board of Directors

    DENVER, June 18, 2019 -- United Cannabis Corporation (OTCBB: CNAB) (the “Company” or “United Cannabis”) today announced the appointment of David J. Scott to the Company’s Board.

  • GlobeNewswire2 months ago

    United Cannabis Corporation Surpasses Significant Hurdle in Pending Patent Litigation

    United Cannabis Corporation (CNAB) (the “Company” or “United Cannabis”) surpassed a significant hurdle in its pending patent infringement case against Pure Hemp Collective when United States District Judge William Martinez held that “[d]espite the ambiguities, the Court is convinced under the current state of the case law that the challenged claims of the 911 Patent are not directed at unpatentable subject matter . The Court also dispensed with Pure Hemp’s contention that Claim 31 of the 911 Patent, a dependent claim that adds a medium chain triglyceride (MCT) to the claimed formulations, was invalid under 35 U.S.C. § 112. Noting that United Cannabis had previously corrected a multiple dependency problem via disclaimer, Judge Martinez held “[i]n short, there is neither a good reason nor a statutory basis to declare Claim 31 invalid, even though it previously depended on multiple dependent claims.

  • GlobeNewswire3 months ago

    United Cannabis Corporation Establishes Partnership With John Easterling, Founder Of Amazon Herb Company

    United Cannabis Corporation (CNAB) (the “Company” or “United Cannabis”) today announced that it has entered into a Partnership with John Easterling, environmentalist and founder of the multi-million dollar Amazon Herb Company, to create and produce formulations that combine the health benefits of cannabinoids with botanicals from the Amazonian Rainforest.

  • ACCESSWIRE4 months ago

    United Cannabis Corporation Establishes Joint Venture for Industrial Hemp Processing Facility in South Carolina

    DENVER, CO / ACCESSWIRE / February 12, 2019 / United Cannabis Corporation (CNAB) (the ''Company'' or ''United Cannabis'') today announced that it has entered into a Joint Venture with Blue Water Green Bridge, LLC (Blue Water) a South Carolina company, to establish an industrial hemp processing plant. The new venture is named Magnolia Botanicals LLC, (''Magnolia''). Initially, Magnolia will provide industrial hemp extraction services for South Carolina farmers working under the 2018 Federal Farm Bill and the South Carolina Department of Agriculture's Industrial Hemp Pilot Program.

  • ACCESSWIRE5 months ago

    These 4 Marijuana Stocks Could Surpass January Highs

    As we've seen over the past couple of months, several countries, including the United States, passed positive legislation in favor of the legalization of cannabis. As we continue to move through this new year, the hopes are that the cannabis industry will be able to see even more gains in the future. Biome Grow Inc (CSE:BIO) (BIOIF) (6OTA.F), Pyxus International Inc (PYX), United Cannabis Corporation (CNAB), and Cannabis Science Inc (OTC PINK: CBIS) are four cannabis companies determined to champion products and services designed with the consumer in mind.

  • GlobeNewswire5 months ago

    Uptick Newswire Hosts United Cannabis Corporation on the Stock Day Podcast to Discuss Their Industrial Hemp Processing Plants and Additional Product Developments

    Uptick Newswire Stock Day Podcast welcomed United Cannabis Corporation (CNAB), a biotechnology company dedicated to the development of phyto-therapeutic based products supported by patented technologies for the pharmaceutical, medical, and industrial markets. President and CEO, Earnie Blackmon, joined Stock Day host Everett Jolly to discuss the Company’s recent developments and their expectations for 2019.

  • ACCESSWIRE5 months ago

    United Cannabis Corporation Opens Colorado Hemp Testing Facility

    DENVER, CO / ACCESSWIRE / January 15, 2019 / United Cannabis Corporation (CNAB) (the "Company" or "United Cannabis") today announced that it has launched an industrial hemp testing facility in Golden, Colorado. The Company will provide independent testing for processors and manufacturers working under the 2018 Federal Farm Bill and Colorado's Department of Agriculture's Industrial Hemp Program.

  • ACCESSWIRE6 months ago

    United Cannabis Corporation Provides Operations Update

    DENVER, CO / ACCESSWIRE / December 13, 2018 / United Cannabis Corporation (CNAB) (the "Company" or "United Cannabis") today provided an update on its operations. The Company experienced a 60-day delay in the delivery of industrial hemp processing equipment to its facility in Mead, Colorado, causing a delay in the scheduled expansion of its capacity at that facility as well as related revenue. The academic laboratory of Dr. Brent Reynolds, cofounder of Prana Therapeutics, Inc., the Company's 95% owned subsidiary, has been issued a Schedule 1 drug license from the DEA.

  • ACCESSWIRE8 months ago

    United Cannabis Corporation Gives Guidance on Third Quarter Results

    Revenues for the third quarter 2018 are $2 million, and approximately $4.2 for the year to date. The current harvest season has alleviated the seasonal shortage and, thus, Management believes the Company is still on track to report a minimum of $10 million in revenue for 2018. The third quarter 2018 revenues amount has not be subjected to an unaudited review by the Company's auditors, and may be subject to change upon the completions of such unaudited review.

  • ACCESSWIRE9 months ago

    United Cannabis Corporation Receives Conditional Approval From Jamaica's Cannabis Licensing Authority

    DENVER, CO / ACCESSWIRE / September 25, 2018 / United Cannabis Corporation (CNAB) (the "Company" or "United Cannabis") today announced that its Joint Venture (the "Joint Venture" or "UCANN/CRD"), which is 50% owned with Jamaica-based Cannabis Research & Development ("CRD"), has received conditional approval of its license to cultivate, process, transport and conduct research on cannabis within Jamaica.

  • ACCESSWIRE11 months ago

    United Cannabis Corporation Begins Clinical Trials On Its Prana P1 THC Activated Capsules For Chronic Pain

    DENVER, CO / ACCESSWIRE / August 1, 2018 / United Cannabis Corporation (CNAB) (the "Company" or "United Cannabis") today announced that it has initiated clinical trials on its Prana Bio Nutrient Medicinals P1 Capsules for the treatment of chronic pain at Jamaica's University of the West Indies. The study, titled, "An Open Label, Phase 1, 2-Way crossover study evaluating the pharmacokinetics of Prana P1 THC activated capsules," is be conducted in conjunction with Cannabinoid Research & Development ("CRD"), the Company's Jamaican subsidiary, at the Centre For Cannabis Research at the University's Mona Campus.

  • ACCESSWIRE11 months ago

    United Cannabis Corporation Gives Guidance on 2018 Results

    Earnest Blackmon, United Cannabis' Chief Executive Officer, commented, "The pilot run of our industrial hemp facility was very successful, resulting in a breakout second quarter. The Company has long advocated the application of cannabinoids for medical applications and is building a platform for designing targeted therapies to increase the quality of life for patients around the world. The Company's products are patent protected, first in class medicines with applications to a global market.

  • ACCESSWIRE11 months ago

    United Cannabis Corporation Prana Bio Nutrient Patent Declared Effective In South Africa

    Earnest Blackmon, United Cannabis' Chief Executive Officer, commented on the approval: "South Africa is one of many markets where medical marijuana is viewed favorably, and we look forward to establishing a strong presence there, and making our Prana products available to qualified patients across the country.